循環器内科 Twitter アカウントlanguage English

英文著書　Text Books in English


＞2021　＞2020　＞2017　＞2015　＞2014　＞2013　＞2011　＞2010　＞2007

緑色のタイトル部分をクリックすると、PDFが表示されます。

【 2021年 】

  1. Takahashi J, Shimokawa H. Epidemiology of vasospastic angina. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 3-19. Springer Nature Singapore, 2021.

  2. Satoh K, Shimokawa H. Pathophysiology and molecular mechanisms of coronary artery spasm. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 21-37. Springer Nature Singapore, 2021.

  3. Nishimiya K, Matsumoto Y, Takahashi J, Shimokawa H. Doagnosis of coronary artery spasm. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 39-57. Springer Nature Singapore, 2021.

  4. Matsumoto Y, Nishimiya K, Ohyama K, Uzuka H, Amamizu H, Takahashi J, Shimokawa H. Treatment of coronary artery spasm. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 59-76. Springer Nature Singapore, 2021.

  5. Ong P, Shimokawa H. Epidemiology of coronary microvascular dysfunction. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 79-95. Springer Nature Singapore, 2021.

  6. Godo S, Shimokawa H. Pathophysiology of coronary microvascular dysfunction. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 97-118. Springer Nature Singapore, 2021.

  7. Takahashi J, Shimokawa H. Diagnosis of coronary microvascular dysfunction. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 119-137. Springer Nature Singapore, 2021.

  8. Takahashi J, Shimokawa H. Treatment of coronary microvascular dysfunction. In: Shimokawa H (ed.). Coronary Vasomotion Abnormalities. pp. 139-155. Springer Nature Singapore, 2021.


【 2020年 】

  1. Satoh K, Shimokawa H. Development of novel therapies for pulmonary hypertension by clinical application of basic research. In: Nakanishi T, Baldwin S, Fineman JR, Yamagishi H (Eds.), Molecular Mechanisms of Congenital Heart Disease and Pulmonary Hypertension, pp. 125-129, Springer, 2020.


【 2017年 】

  1. Ito K, Shindo T, Shimokawa H. Low-energy extracorporeal shock wave therapy. In: Higashi Y, Murohara T (eds.). Therapeutic Angiogenesis. pp. 177-190. Springer Nature, Singapore, 2017.

  2. Satoh K, Sugimura K, Shimokawa H. Rho-kinase as a therapeutic target for pulmonary hypertension. In: Fukumoto Y (ed), Diagnosis and Treatment of Pulmonary Hypertension. From Bench to Bedside, pp. 67-76. Springer Nature, Singapore, 2017.


【 2015年 】

  1. Satoh K, Shimokawa H. Cyclophilin A: Novel biomarker for oxidative stress and cardiovascular diseases. In: Preedy VR, Patel VB (eds), General Methods in Biomarker Research and Their Applications, pp. 405-438, Springer Reference, London, 2015.

  2. Takahashi J, Shimokawa H. Earthquake, cardiovascular diseases and implications for public health. In Watson RR, Tabor JA, Ehiri JE, Preedy (eds.), Handbook of Public Health in Natural Disasters, pp.309-333, Wageningen Academic Publishers, The Netherlands, 2015.


【 2014年 】

  1. Sakata Y, Shimokawa H. Ischemic heart disease. In: Wakabayashi I, Groschner K (eds), Interdisciplinary Concepts of Cardiovascular Health. Volume III. pp.1-17. Springer, Wien, Austria. 2014.

  2. Shimokawa H. Coronary artery spasm: Basic aspect. In Lanzer P, Topol EJ (Eds), PanVascular Medicine, Springer, Berlin-Heidelberg-New York. 2014.

  3. Shimokawa H. Coronary artery spasm: Clinical aspect. In Lanzer P, Topol EJ (Eds), PanVascular Medicine, Springer, Berlin-Heidelberg-New York. 2014.


【 2013年 】

  1. Fukumoto Y, Shimokawa H. Rho-kinase inhibitors. In: Humbert M, Evgenov OV, Stasch JP (eds), Pharmacotherapy of Pulmonary Hypertension, Handbook of Experimental Pharmacology Vol.218., pp.351-363. Springer, Berlin-Heidelberg, 2013.

  2. Yasuda S, Shimokawa H. The Pathogenesis of Vasospastic Angina. In: Kaski JC, Eslick GD, Bairey Merz CN (eds.), Chest Pain with Normal Coronary Arteries, pp.91-99. Springer-Verlag, London, UK, 2013.


【 2011年 】

  1. Henk EDJ ter Keurs, Ni Diao, Nathan P. Deis, Mei L Zhang, Yoshinao Sugai, Guy Price, Yuji Wakayama, Yutaka Kagaya, Yoshinao Shinozaki, Penelope A Boyden, Masahito Miura, Bruno DM Stuyvers. 16. Heterogeneity of sarcomere length and function as a cause of arrhythmogenic calcium waves. Peter Kohl, Frederick Sachs and Michael R. Franz. ed. In Cardiac Mechano-Electric Coupling and Arrhythmias (2nd edition). OXFORD UNIVERSITY PRESS. pp.117-125, 2011.


【 2010年 】

  1. Shimokawa H, Ito K. Extracorporeal cardiac shock wave therapy for ischemic heart disease. In: Achim M. Loske (ed.), New Trends in Shock Wave Applications to Medicine and Biotechnology, Research Signpost, India, 211-224,2010.


【 2007年 】

  1. Nishida T, Shimokawa H. Extracorporeal cardiac shock wave therapy as a new therapeutic option for ischemic cardiomyopathy. Gerdesmeyer L, Weil LS (eds.), Extracorporeal Shock Wave Therapy, pp.111-118, Data Trace Publishing Co., 2007.